Nevada made the agreement mandatory.It should make continuity mandatory too.
Nevada law requires a prescription medication agreement when certain controlled substances continue beyond 30 days. The agreement should support an honest clinical relationship, not become a trapdoor to abrupt tapering, dismissal, or loss of care.
The form is compulsory. Fair process is not.
NRS 639.23914 requires an agreement after 30 days and specifies its contents. The statute does not supply a clear statewide process for notice, explanation, confirmation testing, review, or safe transition when a dispute over that agreement threatens established treatment.
Name the authority before judging the decision.
Nevada statute, licensing enforcement, pharmacy judgment, Medicaid coverage, and clinic policy are separate instruments. A patient should be told which one actually caused an interruption.
NRS Chapter 639
The Legislature sets initial prescribing duties, informed consent, the 30 day agreement, and the 90 day review framework.
Licensing boards
Boards enforce standards within their jurisdiction. A statutory threshold does not by itself decide what treatment is appropriate for a particular patient.
Payers, pharmacies, and clinics
Prior authorization and internal policy can affect access, but they do not silently rewrite Nevada law or replace individualized medical judgment.
Nevada built three decision points into one treatment path.
Evaluation and consent
NRS 639.23911 and 639.23912 require a relationship, assessment, treatment discussion, and documented informed consent before an initial prescription.
Medication agreement
NRS 639.23914 requires a written agreement for treatment extending beyond 30 days and identifies terms involving goals, use, testing, disclosure, and possible change or discontinuation.
Reassessment
NRS 639.23913 requires diagnosis, risk review, treatment plan discussion, and further documentation for continued treatment, including added analysis at 90 MME or more.
Protect the process without promising a prescription.
Patient specific safety judgment
A practitioner may respond to serious harm, diversion, unsafe combinations, material deception, or another documented clinical concern. Reform does not compel treatment that lacks a legitimate medical purpose.
Automatic consequences
A signature dispute, test result, dosage threshold, or administrative condition should prompt inquiry and review, not automatic abandonment or an unsafe dose change.
A shared clinical record
It should document goals, responsibilities, safety information, and communication in language the patient can understand.
A waiver of ordinary care
It should not erase notice, confirmation, explanation, disability accommodation, language access, or a clinically appropriate transition.
Add a continuity protocol to the required agreement.
- Amend NRS 639.23914 so an agreement must state the patient’s right to an explanation, review, and safe transition.
- Prohibit abrupt discontinuation or dismissal based solely on an agreement term, dosage threshold, or single screening result when no immediate serious harm is documented.
- Require confirmation of unexpected toxicology results when clinically appropriate and allow the patient to provide relevant medical or factual context.
- Require a written, patient specific reason for an adverse treatment decision and identify whether it arose from statute, clinical judgment, coverage, pharmacy practice, or institutional policy.
- Require prompt review, necessary bridge care, records transfer, and direct referral when established treatment cannot continue.
- Publish aggregate data on agreement related tapers, dismissals, interruptions, reviews, reversals, and emergency care.
Give Nevada text it can adopt.
A prescription medication agreement shall support informed and individualized care. No established patient shall be dismissed, required to taper, or denied continuation solely because of a dosage threshold, an administrative term, or a single screening result without a documented patient specific clinical assessment.
Before a nonemergency adverse decision, the practitioner shall provide the patient a meaningful explanation, an opportunity to provide relevant information, prompt clinical review, and a safe transition plan that may include confirmation testing, appropriate bridge care, records transfer, and direct referral.
Move from signature to accountable care.
Publish the baseline
Measure how required agreements are written, translated, renewed, enforced, and connected to treatment interruptions across Nevada.
Hear the affected record
Take testimony from patients, prescribers, pharmacists, tribal communities, rural communities, disability advocates, payers, and recovery specialists.
Amend the statute
Add notice, contextual review, confirmation when appropriate, and continuity duties directly to NRS 639.23914.
Align implementation
Require boards, Medicaid, managed care plans, health systems, clinics, and pharmacies to identify the source of every operative restriction.
Audit the outcome
Track interruptions, reviews, reversals, emergency care, overdose, suicide risk, travel burden, and access to receiving clinicians.
Make the agreement answerable to evidence.
Send each correction to its owner.
| Authority | Instrument | Proper request |
|---|---|---|
| Nevada Legislature | NRS 639.23914 | Add notice, review, confirmation, and continuity protections to the mandatory agreement. |
| Professional licensing boards | Enforcement and guidance | Protect good faith individualized care and distinguish evidence from automatic conclusions. |
| Nevada Medicaid and managed care | Coverage criteria | Identify coverage decisions clearly and provide timely patient specific review. |
| Pharmacies | Dispensing judgment and policy | State the actual reason for a refusal and communicate directly when continuity is at risk. |
| Health systems and clinics | Agreement forms and operating policy | Remove automatic punishment and build a documented escalation and transition path. |
Nevada can strengthen safety by strengthening trust.
Keep shared expectations
The required agreement can help patient and practitioner define the purpose of treatment and review whether it remains useful.
Keep relevant information
Prescription history, risk assessment, toxicology when clinically appropriate, and documented follow up can support safer decisions.
Keep individualized action
Clinicians must remain able to respond to real danger. The reform asks that the reason be patient specific and the response proportionate.
Open the controlling documents.
Precision protects the reform.
What the record supports
- Nevada requires an agreement when covered controlled substance treatment extends beyond 30 days.
- The agreement must address goals, safe use, monitoring, disclosures, and reasons treatment may change or stop.
- Separate 90 day duties require reassessment and documentation.
- The statute preserves distinct treatment provisions for cancer, sickle cell disease, hospice, and palliative care.
What the record does not establish
- An agreement breach automatically proves misuse or diversion.
- A single test result establishes the full clinical facts.
- Every treatment above 90 MME is prohibited.
- A payer rule or clinic policy is identical to Nevada statute.
This Atlas is public policy education and source mapping, not legal advice or individual medical advice. Patients should not abruptly change medication or treatment based on this page.
If Nevada requires the agreement, Nevada should require a fair exit from it.
Keep the goals, monitoring, and professional responsibility. Add notice, context, review, and safe continuity when an established patient’s care is at stake.